Redmile Group, LLC

10% OwnerADC Therapeutics SA (ADCT) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$19.6M
Net Open-Market Flow
-$19.6M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Sell(S)2.6M$3.28$8.6M12.7M
Apr 2, 2026Sell(S)2.5M$3.28$8.3M10.3M
Apr 1, 2026Sell(S)169K$3.80$643K15.3M
Apr 1, 2026Sell(S)163K$3.80$617K12.8M
Mar 31, 2026Sell(S)196K$3.75$736K15.5M
Mar 31, 2026Sell(S)188K$3.75$707K13.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-039359) within minutes of acceptance. Every field above traces to the original document. Verify it directly: